Adaptimmune Therapeutics plc Made Big Gain

Tue, Nov 08, 2022 at 07:54 PM
Adaptimmune Therapeutics plc Made Big Gain

Adaptimmune Therapeutics plc (ADAP:NASDAQ) shot up at $2.08, representing a gain of 25.3%. On Tue, Nov 08, 2022, ADAP:NASDAQ touched a New 2-Week High of $2.08. The stock got featured on our News Catalysts scanner on Tue, Nov 08, 2022 at 07:49 AM in the 'BIOTECH' category. From Tue, Oct 25, 2022, the stock recorded 100.00% Up Days and 90.91% Green Days

About Adaptimmune Therapeutics plc (ADAP:NASDAQ)

Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.